CD4 and neoplasm: First, on the anti-tumor immunity: indeed, in human tumors a skew towards Th2 type of tumor-specific CD4+ T cells has been described in patients with advanced malignancies [20], [21], [22], while high levels of infiltrating Th1 cells in the tumors correlate with a better prognosis [23].